Arbutus Biopharma Corp (ABUS) vs LB Pharmaceuticals Inc Common Stock (LBRX)

A side-by-side comparison of Arbutus Biopharma Corp and LB Pharmaceuticals Inc Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Arbutus Biopharma Corp logo
ABUS
Arbutus Biopharma Corp
$885M
$4.48HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
LB Pharmaceuticals Inc Common Stock logo
LBRX
LB Pharmaceuticals Inc Common Stock
$982M
$34.26HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — ABUS vs LBRX

growth of $100 · dividends reinvested · last 1y
ABUS +1.1% (+1.1%/yr)LBRX +100.1% (+100.1%/yr)LBRX compounded faster over this window
100150200250300Start $1002026$101$200
ABUS LBRX

ABUS vs LBRX: by the numbers

  • •LBRX is the larger company ($982M vs $885M market cap).
  • •ABUS is profitable (84.23% net margin) while LBRX runs a net loss (0.00%).

Metrics side by side

Valuation

MetricABUSLBRX
P/E ratio5.74N/A
Forward P/E6.05N/A
P/S ratio4.87N/A
P/B ratio3.422.96
EV / EBITDA5.90N/A

Profitability

MetricABUSLBRX
Gross margin99.98%0.00%
Operating margin-192.08%0.00%
Net margin84.23%0.00%
ROE59.16%-25.78%
ROIC54.39%-28.14%

Growth (annualized)

MetricABUSLBRX
Revenue CAGR (5Y)85.17%N/A
Total return CAGR (5Y)2.19%N/A

Frequently asked

Is ABUS or LBRX more profitable?
ABUS runs the higher net margin — ABUS at 84.23% versus LBRX at 0.00%.

Go deeper

Full ABUS analysisFull LBRX analysisInteractive comparison tool

Dig into the metrics

Arbutus Biopharma P/E ratioArbutus Biopharma ROELB Pharmaceuticals Inc Common Stock ROEArbutus Biopharma operating marginLB Pharmaceuticals Inc Common Stock operating marginArbutus Biopharma revenue growthLB Pharmaceuticals Inc Common Stock revenue growthArbutus Biopharma free cash flowLB Pharmaceuticals Inc Common Stock free cash flow

Arbutus Biopharma & LB Pharmaceuticals Inc Common Stock appear in these rankings

Fastest Revenue Growth StocksHighest ROE StocksHighest ROIC StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.